EW News and Press, Edwards Lifesciences Corporation From 01/30/20

Edwards Lifesciences (NYSE: EW ) Q4 results : More news on: Edwards Lifesciences Corporation, Healthcare stocks news, Earnings news and commentary, , Stocks on the move, Read more ...

Edwards Lifesciences (NYSE: EW ): Q4 Non-GAAP EPS of $1.46 misses by $0.03 ; GAAP EPS of $1.32 misses by $0.09 . Revenue of $1.17B (+19.7% Y/Y) beats by $20M . Press Release More news on: Edwards Lifesciences Corporation, Earnings news and commentary, Healthcare stocks news,

Safety First: NASCAR driver Johanna Long and her helmet (Credit: Gearheads ) Revisiting Our Revised Security Selection Method Since June 2017, I've run a Marketplace service which has an " investing with a helmet on " approach: I present concentrated portfolios where each security is he...

Introduction For today's analysis of Edwards Lifesciences ( EW ) stock, I calculate what I consider to be the two main drivers of future total returns for stock investments: Returns that come from changes in market sentiment, and returns that come from earnings. I calculate these expected re...

So far, stock market tailwinds because of end of year bonuses, retirement plan contributions, and institutional re-positioning have offset data suggesting the market is overbought. However, a 3% to 5% correction is getting more likely as the rally broadens out (excluding energy), suggesting in...

Edwards Lifesciences ( EW -5.4% ) slips on average volume in apparent response to a Jefferies report of a "sharp step down" last month in the growth of heart valve replacements. More news on: Edwards Lifesciences Corporation, Healthcare stocks news, Stocks on the move, Read more ... ...

IRVINE, Calif. , Jan. 16, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended December 31, 2019 af...

It was more of the same in the stock market last week in terms of returns, but the catalysts supporting the rally shifted from easing trade tensions and dovish Federal Reserve policy to a deescalating of tensions between the U.S. and Iran. Specifically, a tepid Iranian response to the U.S. str...

Shares of Edwards Lifesciences (NYSE: EW) soared over 52% last year, according to data provided by S&P Global Market Intelligence . The company, which specializes in medical devices used to address structural heart disease, delivered impressive revenue gains and steadily improved full-y...

Aerie Pharmaceuticals (NASDAQ: AERI ) initiated with Neutral rating and $27 (6% upside) price target at Bank of America. More news on: Aurinia Pharmaceuticals Inc., BeyondSpring Inc., Cerecor Inc., Healthcare stocks news, Stocks on the move, , Read more ...